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Abstract: Aim: To prospectively evaluate the effects of an oral contraceptive
containing the progestin gestodene on carbohydrate metabolism in ordinary Turkish 
women 
Material / Method: Carbohydrate metabolism was prospectively evaluated in 53 normal
women prior to and during their use of monophasic oral contraceptive containing the
progestin gestodene plus ethinyl estradiol for one year. The women had a two hour 
oral glucose tolerance test using 75 gram glucose load, measuring serum glucose and
insulin level, performed at the beginning of the contraceptive therapy and after one
year. 
Results: The results demonstrate no significant changes in either of carbohydrate 
metabolic indices between the two tests.   
Conclusion: The progestin containing contraceptive pill can be safely used in
consideration of the carbohydrate metabolism. 
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INTRODUCTION: 
One major concern about oral contraceptive use has been the secondary effects of the
steroids on metabolic indices of the user. Studies have previously shown that the 
progestin component of these drugs can affect carbohydrate metabolism and produce 
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an elevation of both serum glucose and insulin levels (1). To reduce potentially
adverse side effects, new progestin containing contraceptive market has expanded
over the passing time.  This study was designed to prospectively evaluate the effect of 
a gestodene-containing oral contraceptive on the carbohydrate metabolism over one
year of combined drug use, while measuring both serum glucose and insulin levels
during an oral glucose tolerance test. 
  
MATERIAL AND METHOD: 
The subjects consisted of 53 volunteers using oral contraceptives.  All were more than 
one year postpartum or had not used oral contraceptives for that length of time. After 
the study was explained, each woman gave their informed consent. The study was
conducted with the approval of the ethical study board of Zeynep Kamil Hospital. Each
subject provided a medical history and underwent a thorough physical examination;
which included a pelvic examination and pap smear. No significant pathological states 
were found. Before initiating the use of the contraceptives, the women had a control
glucose tolerance test. They were instructed to eat a high - carbohydrate diet for 3 
days before the test and then to report to the laborotory between 0800-0900 hours 
after fasting for more than two hours; their weights were recorded and they were
seated for the duration of the test. An antecubital venous blood sample was drawn
and they were asked to drink a flavoured solution containing 75 gr of glucose . The 
blood was placed in tubes for glucose and insulin analysis respectively, allowed to clot,
centrifuged and the serum was separated. The samples for glucose analysis were
stored at 4°C and the samples for insulin analysis analysis were stored at -
20°C.Repeat venous blood samples were drawn after 0.5, 1, 2, and 3 hours .Following 
completion of the test, each women was given her package of steroid contraceptives
and instructed concerning their use. The monophasic oral contraceptive (had 21 active
tablets per month and each contained 75mg gestodene and 30mg ethinyl estradiol.The 
women were seen periodically afterwards to replace pill packs and to answer
questions.  In the every third month of use each subject served as her own control. In
the end of one year, all women returned and the last week of the pill cycle,they had an 
identical oral glucose tolerance test. 
The serum samples were later analyzed in duplicate for their glucose content using a
Beckman Glucose Analyzer 2.The inter-assay and intra-assay precision had a standart 
deviation less than 3.0 and 2.5 mg/dl respectively. An aliquot of the samples were also
analyzed in duplicate for its insulin content using radioimmunoassay (I125  Insulin-Kits 
purcharged from diagnostic Products corporation ).All samples from the control and
three months tests on one subject were analyzed by the Beckman Gamma 5500B
Counter,which were later transported to the Beckman Data Capture program and were
analyzed by Beckman Immunofit EIA/RIA program ,using a logit-log curve fit. The inter-
assay and intra-assay coefficients of variation did not exceed 10% in the 5-200 unit/ml 
range,according to the precision profiles (2).  
The data were analyzed for the means and standart errors of the means. The changes
in values between the control and one year test were compared with paired student’s t-
tests.  The propability values were taken from two - tailed tables and only values 
p<0.05 were considered significant. 
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RESULTS: 
The subjects presented with characteristics similar to those in most contraceptive
programs, with a mean age 27.4 (± 0.2 years). The group mean weight was 63 ± 5.6
kg.  After one year of drug usage it was not significantly different (mean 64.6 ± 5.7 kg).
The glucose results from the two tests are given in Table 1. None of the values
changed significantly between the two tests in plasma glucose results.  
The statistical studies of the insulin values are provided in Table 2. Although the mean
values are elevated at the twelve month test,none of the canges were statistically
significant.  
  
DISCUSSION: 
Oral contraceptives were approved for use in the USA in 1960(2), and for use in the
Turkey in 1965(3) and since then have been a major method of family planning for
millions of women. A multitude of studies over the past thirty years have evaluated
their efficacy, side-effect and systemic effects in users were steroid-specific and dose 
dependent(3). For example, venous thrombosis has been found to be mainly an
estrogen effect and altered carbohydrate metabolism to be a progestin effect (4). The
pharmaceutical industry modifed the drugs to improve their safety. Two major
modifications have been the reduction in total steroid dosage the development and use
of new steroids. As the new formulation became available they too needed testing to
determine whether their contraceptive efficacy, control of cycle bleeding, or prevalence
of adverse effects were reduced (5, 6). 
The effects of a new contraceptive containing the progestin gestodene on
carbohydrate metabolism in women were studied. Gestodene is similar chemically to
levonorgestrel , except for having a double bond at the carbon fiftheen position.
Gestodene has been shown to bind strogly to both androgen and progestin receptors
and to have little affinity for estrogen receptors (7,8).The results showed no statistically
significant changes concerning the carbohydrate metabolic status of the subjects after
one year use of the pill. 
This study showed the safe use and relatively acceptable side- effects of a new 
contraceptive containing progestin; gestodene on carbohyrate metabolism in normal 
Turkish women 
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CONTROL                                              12 MONTH 
Time in 
hours 
Fasting 0.5 1 1.5 2 Fasting 0.5 1 1.5 2 
   
Mean 
   
76.7 
   
125.9 
   
108.5
   
89.9 
   
68.3 
   
78.9 
   
127.8
   
120.2 
   
99.1 
   
74.4 
   
SEM 
   
2.3 
   
5.5 
   
7.2 
   
4.9 
   
3.1 
   
2.5 
   
6.3 
   
7.9 
   
4.7 
   
6.0 
T  
VALUES* 
0.69 0.42  
  
  
1.34 1.35  
  
0.84  
  
  
          
 *Probability. 
Table 1. Serum glucose values in mg/dl for the control and 12 month oral glucose
tolerance test in normal women using a gestodene containing oral contraceptive (
n=53) 
  
CONTROL                                              12 MONTH 
  
  
  
  
*Probability  
Table  2. Serum insulin values in munits/ml for the control and 12 month oral
glucose tolerance test in normal women using a gestodene containing oral
contraceptive (n =53) 
  
Time in 
hours 
Fasting 0.5 1 1.5 2 Fasting 0.5 1 1.5 2 
 Mean  7.4  58.4  57.9  48.7  16.2  8.8  67.2  73.6  56.9 31.7 
 SEM  0.8  5.9  5.8  6.0  2.9  0.9  6.2 8.7 7.5  8.7 
 T 
Values* 
 1.46  1.39  1.82  1.06  2.05           
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